Cardiac

  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Terumo recalls stent-graft system linked to three deaths

    Terumo has yet to establish a direct causal relationship between the deaths and the delivery system separation issues.

    By • July 2, 2026
  • A view of the Edwards Lifesciences headquarters building with three people walking in front.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic

    Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.

    By • June 29, 2026
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Robotic surgery's innovation boom

    Surgical robotics is one of the most exciting spaces in the medical device industry, with companies developing new systems and battling for market share.

    By MedTech Dive staff
  • A ShockWave sonic catheter
    Image attribution tooltip
    Permission granted by ShockWave
    Image attribution tooltip

    J&J starts pivotal trials of Shockwave IVL device in carotid arteries

    J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like Boston Scientific and Stryker.

    By • June 29, 2026
  • an interior shot of johnson and Johnson corporate lobby featuring signage
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    FDA posts early alert over device used with Impella heart pumps

    J&J’s Abiomed and manufacturing partner Oscor warned of a bleeding risk from devices used to introduce catheters to the body. 

    By • June 22, 2026
  • Illustration of a blood clot blocking red blood cells within an artery or a vein.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Penumbra wins CE mark for Thunderbolt clot removal tech

    The international launch could benefit from Boston Scientific’s global footprint when the company closes its takeover of Penumbra.

    By • June 18, 2026
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Medtech M&A maintains momentum following decade-high 2025: PwC

    Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.

    By • June 17, 2026
  • An artificial heart valve is shown against a white background.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    CMS proposes Medicare coverage expansion for TAVR

    The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.

    By • June 16, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J recalls Impella controllers over hardware issues

    The correction is the latest recall that J&J’s Abiomed has issued in recent years for Impella devices and controllers.

    By • June 12, 2026
  • Triformis Resilia surgical tricuspid valve replacement
    Image attribution tooltip
    Permission granted by Edwards Lifesciences
    Image attribution tooltip

    Edwards gets FDA approval for surgical tricuspid valve

    Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.

    By • June 3, 2026
  • Johnson & Johnson's Impella CP heart pump is shown in an illustration of the heart.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J recalls Impella heart pumps after patient dies

    Johnson & Johnson asked customers to quarantine and return affected products. A spokesperson said J&J conducted quality system audits as part of its integration of Abiomed that resulted in some field actions.

    By • May 29, 2026
  • J&J, Auris, Fortis
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J corrects Impella controller over issue linked to 2 injuries, 1 death

    The controller can stop for about 35 seconds, during which time the patient is unsupported by the heart pump.

    By • May 26, 2026
  • The Medtronic logo is displayed on an office building.
    Image attribution tooltip
    Retrieved from Medtronic on May 11, 2026
    Image attribution tooltip

    Medtronic to create European software hub in Ireland

    The investment in cardiac digital health will add 85 jobs initially, with more growth expected over the next three years.

    By • May 22, 2026
  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic data back renal denervation in the long term

    Analyses presented at EuroPCR assessed Medtronic’s Symplicity blood pressure procedure in patient groups with severe hypertension and who had prior cardiovascular events.

    By • May 20, 2026
  • Illustration of a blood clot blocking red blood cells within an artery or a vein.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Endologix buys clot removal system from Surmodics

    Endologix will market the system to vascular interventionists who use its other devices to treat peripheral artery disease and abdominal aortic aneurysms.

    By • May 20, 2026
  • A catheter device is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific posts positive data for coronary IVL catheter

    With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for patients with severely calcified coronary artery disease.

    By • May 19, 2026
  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Artivion closes Endospan buyout to acquire recently approved heart device

    Artivion is targeting a $150 million annual U.S. market for the Nexus Aortic Arch System.

    By • May 19, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific buys $1.5B stake in TAVR developer MiRus

    The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional payments totaling $3 billion.

    By • May 18, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J launches improved Shockwave catheter

    The latest generation of the coronary intravascular lithotripsy device is designed to be more flexible to help physicians navigate tight arteries to break up calcified deposits and restore blood flow.

    By • May 13, 2026
  • The Medtronic logo is displayed on an office building.
    Image attribution tooltip
    Retrieved from Medtronic on May 11, 2026
    Image attribution tooltip

    Medtronic to close California site amid restructuring

    The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several businesses within its cardiovascular portfolio.

    By • May 11, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott gets FDA nod, CE mark for AI-enabled imaging device

    The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.

    By • May 4, 2026
  • A closeup of the porcine heart valve against a white background.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic wins FDA approval for updated mitral replacement valve

    Surgeons have performed initial implants of the Mosaic Neo valve at centers across the U.S., as well as the first robotic implantation.

    By • April 29, 2026
  • A picture of a blue pulsed field ablation catheter against a gray background.
    Image attribution tooltip
    Courtesy of Johnson & Johnson MedTech
    Image attribution tooltip

    J&J starts head-to-head PFA trial against Boston Scientific device

    The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.

    By • April 28, 2026
  • Boston Scientific's Farawave pulsed field ablation catheter is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    4 studies to know from HRS 2026

    Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where market share shifts in pulsed field ablation were on analysts’ minds.

    By • April 27, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J to acquire Atraverse Medical

    The FDA-cleared radiofrequency guidewire will slot into J&J’s fast-growing cardiovascular portfolio.

    By • April 27, 2026
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards raises 2026 forecast as TAVR sales surge

    The stronger outlook follows mixed results from other major medical device makers in the latest quarter, after both Abbott and Boston Scientific cut their full-year guidance.

    By • April 24, 2026